KarimJarirHalazunMD
General Surgery • New York, NYBariatric Surgery, Hepatobiliary Surgery, Transplantation, Minimally Invasive Surgery
Professor of Surgery
Dr. Halazun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
403 E 34th St
Third Floor Room 308
New York, NY 10016- Is this information wrong?
Summary
- Dr. Karim Halazun is a surgeon NYC. He received his medical degree from University of Leeds and has been in practice 15 years. He speaks multiple languages, including Arabic, French, and Spanish. He specializes in hepatobiliary surgery, liver transplantation, & minimally invasive liver surgery. He is experienced in liver & biliary malignancies, surgical oncology, transplant surgery and GI surgery.
Education & Training
New York Presbyterian Hospital (Columbia and Cornell Campus)Fellowship, Advanced GI Minimally Invasive Surgery, 2011 - 2013- New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 2008 - 2011
University of Leeds School of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2011 - 2026
GA State Medical License 2013 - 2016- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Vanguard Prize ASTS, 2015
- Junior Investigator Award American Society of Transplant Surgeons, 2015
- Blackemore Award Columbia University Medical Center, 2011, 2013
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsWaitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250...Tanveen Ishaque, Sommer Gentry, Jacqueline Garonzik-Wang, Allan B Massie, James Beckett, Sunil Karhadkar, Bonnie E Lonze, Karim J Halazun, Dorry Segev> ;Transplantation. 2024 Mar 29
- Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis.Holzner, M., Mazzaferro, V., Busset, M., Aldrighetti, L., Ratti, F., Hasegawa, K., Arita, J., Sapisochin, G., Abreu, P., Schoning, W., Schmelzle, M., Nevermann, N., Pr...> ;Annals of Surgical Oncology. 2024 Feb 9
- Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American Experience.Ivanics, T., Claasen, M., Samstein, B., Emond, J., Fox, A., Pomfret, E., Pomposelli, J., Tabrizian, P., Florman, S., Mehta, N., Roberts, J., Emamaullee, J., Genyk, Y.,...> ;Annals of Surgery. 2024 Jan 1
- Join now to see all
Press Mentions
Study Suggests Better Prediction Model for Selecting Transplant Patients to Treat Liver CancerJune 24th, 2021- Novel HCC Selection Tool: Better Outcome Predictor for Liver Transplant PatientsMay 7th, 2021
In the Next IssueAugust 23rd, 2017- Join now to see all
Professional Memberships
- Member
- American Society of Transplant SurgeonsMember
- American Association for the Study of Liver DiseaseMember
- American Hepto-Pancreatico-Biliary Association (AHPBA)Member
Other Languages
- Arabic, French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
